Status:
COMPLETED
Generic Testing of Antigen Tests for COVID-19 in Denmark
Lead Sponsor:
Hvidovre University Hospital
Collaborating Sponsors:
Aalborg University Hospital
Herlev and Gentofte Hospital
Conditions:
SARS-CoV2 Infection
COVID-19 Testing
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the analytical and clinical sensitivity and specificity of antigen tests performed as oropharyngeal swabs, outer nasal swabs, saliva swabs or breath tests including self-tests for SARS-CoV...
Eligibility Criteria
Inclusion
- Age 18 years or over,
- Capacity to give informed, written consent
- Be able to cooperate to the additional testing.
Exclusion
- Individuals not fulfilling the inclusion criteria
- Declining additional oropharyngeal, nasal or saliva swabs.
Key Trial Info
Start Date :
January 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 9 2021
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT04913116
Start Date
January 18 2021
End Date
September 9 2021
Last Update
January 26 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark, 8200
2
Hvidovre University Hospital
Hvidovre, Denmark, 2650
3
Odense University Hospital
Odense, Denmark, 5000